肝硬化患者门静脉血栓形成的临床表现和危险因素

周仁华; 李鹏; 张艳婷; 杨花; 杨少奇

doi:10.3969/j.issn.1001-5256.2016.02.015

肝硬化患者门静脉血栓形成的临床表现和危险因素

DOI: 10.3969/j.issn.1001-5256.2016.02.015

1. 宁夏医科大学
2. 宁夏医科大学总医院消化内科

详细信息

中图分类号: R575.2
计量
- 文章访问数: 2368
- HTML全文浏览量: 17
- PDF下载量: 477
- 被引次数: 0
出版历程
- 收稿日期: 2015-07-08
- 出版日期: 2016-02-20

Clinical manifestations of portal vein thrombosis and related risk factors in patients with liver cirrhosis

Ningxia Medical University

摘要

摘要:
目的研究肝硬化患者门静脉血栓（PVT）形成的临床表现及危险因素。方法收集2008年4月-2015年4月宁夏医科大学总医院收治的肝硬化患者资料541例。其中76例肝硬化合并PVT的患者为研究组,同阶段通过匹配患者的性别、年龄及肝功能Child-Pugh分级,76例肝硬化不合并PVT为对照组。对比分析两组患者的临床资料及相关检查指标。计量资料组间比较采用t检验,计数资料组间比较采用χ2检验,并应用非条件Logistic回归模型筛选肝硬化PVT形成的独立危险因素。结果肝硬化PVT患者中,42.1%（32/76）隐匿起病,57.9%（44/76）有明显临床表现。大部分患者肝功能分级为Child-Pugh B和C级。血小板、血糖、中性粒细胞百分比、重度食管胃底静脉曲张、血浆D-二聚体、门静脉宽度、脾脏厚度在两组患者中差异有统计学意义（P值均<0.05）。进一步非条件Logistic回归模型分析显示中性粒细胞百分比[比值比（OR）=1.044,P=0.040]、血浆D-二聚体（OR=0.091,P<0.001）、门静脉宽度（OR=0.030,P=0.008）、脾脏厚度（OR=0.427...
- 肝硬化 /
- 静脉血栓形成 /
- 门静脉 /
- 危险因素
Abstract:
Objective To investigate the clinical manifestations of portal vein thrombosis( PVT) and related risk factors in patients with liver cirrhosis. Methods A total of 541 patients with liver cirrhosis who were admitted to the General Hospital of Ningxia Medical University from April 2008 to April 2015 were included in the study; 76 patients with PVT were enrolled in the study group,and another 76 patients without PVT matched for sex,age,and Child- Pugh class were enrolled in the control group. The clinical data and related indicators were analyzed and compared between the two groups. The t- test was applied for comparison of continuous data between groups,the chi- square test was applied for comparison of categorical data between groups,and the unconditional logistic regression model was used to determine the independent risk factors for PVT in liver cirrhosis. Results In the patients with liver cirrhosis and PVT,42. 1%( 32 /76) had an insidious onset and 57. 9%( 44 /76) had obvious clinical manifestations. Most patients had Child- Pugh class B and C cirrhosis. There were significant differences between the two groups in platelet count,blood glucose,percentage of neutrophils,severe esophageal and gastric varices,plasma D- dimer,portal vein width,and thickness of the spleen( all P < 0. 05). The unconditional logistic regression model analysis showed that percentage of neutrophils( OR = 1. 044,P = 0. 040),plasma D- dimer( OR = 0. 091,P = 0. 000),portal vein width( OR =0. 030,P = 0. 008),and thickness of the spleen( OR = 0. 427,P = 0. 003) were the influencing factors for PVT. Conclusion PVT may have an insidious onset in patients with liver cirrhosis,or have different clinical manifestations. Cirrhotic PVT usually occurs in patients with advanced liver cirrhosis,and plasma D- dimer,portal vein width,thickness of the spleen,and percentage of neutrophils are the independent influencing factors for PVT in patients with liver cirrhosis.
- liver cirrhosis /
- venous thrombosis /
- venous /
- risk factors

HTML全文

参考文献(17)

[1]TSOCHATZIS EA,SENZOLO M,GERMANI G,et al.Systematic review:portal vein thrombosis in liver cirrhosis[J].Aliment Pharmacol Ther,2010,31(3):366-374.

[2]Chinese Society of Infectious Diseases and Parasitology,Chinese Society of Hepatology,Chinese Medical Association.Viral hepatitis prevention and treatment of plan[J].Chin J Infect Dis,2001,19(1):56-62.(in Chinese)中华医学会传染病与寄生虫病学分会,中华医学会肝病学分会.病毒性肝炎防治方案[J].中华传染病杂志,2001,19(1):56-62.

[3]Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association.Guidelines for diagnosis and treatment of alcoholic diseases[J].Chin J Hepatol,2006,14(3):164-166.(in Chinese)中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):164-166.

[4] Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association,Chinese Medical Association.Guidelines for prevention and treatment of alcoholic liver disease(revised version 2010)[J].J Clin Hepatol,2010,26(3):229-232.(in Chinese)中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南(2010年修订版)[J].临床肝胆病杂志,2010,26(3):229-232.

[5]CHEN H,HE CY,HAN GH.Prevention and therapeutic progress in portal vein thrombosis in liver cirrhosis[J].Chin J Dig,2014,34(1):7-10.(in Chinese)陈辉,何创业,韩国宏.肝硬化门静脉血栓预防和治疗进展[J].中华消化杂志,2014,34(1):7-10.

[6]SMALBERG JH,KRUIP MJ,JANSSEN HL,et al.Hypercoagulability and hypo brinolysis and risk of deep vein thrombosis and splanchnic vein thrombosis:similarities and differences[J].Arterioscler Thromb Vasc Biol,2011,31(3):485-493.

[7]SAUGEL B,LEE M,FEICHTINGER S,et al.Thrombophilic factor analysis in cirrhotic patients with portal vein thrombosis.J Thromb Thrombolysis,2015,40(1):54-60.

[8]ROMERO GóMEZ M,SUREZGARCIA E,LóPEZ LACOMBA D,et al.Antiphospholipid antibodies are related to portal vein thrombosis in patients with liver cirrhosis[J].J Clin Gastroenterol,2000,31(3):237-240.

[9]MANGIA A,VILLANI MR,CAPPUCCI G,et al.Causes of portal venous thrombosis in cirrhotic patients:the role of genetic and acquired factors[J].Eur J Gastroenrol Hepatol,2005,17(7):745-751.

[10]KUMAR S,SARR MG,KAMATH PS.Mesenteric venous thrombosis[J].N Engl J Med,2001,345(23):1683-1688.

[11]GARDINER C,PENNANEACH C,WALFORD C,et al.An evaluation of rapid D-dimer assays for the exclusion of deep vein thrombosis[J].Br J Haematol,2005,128(5):842-848.

[12]ZOCCO MA,DI STASIO E,de CRISTOFARO R,et al.Thrombosis risk factors in patients with liver cirrhosis:correlation with MELD scoring system and portal vein thrombosis development[J].J Hepatol,2009,51(4):682-689.

[13]ZHANG L,WANG L,YANG GM.Analysis of risk factors of portal vein thrombosis in liver cirrhosis[J].Chin J Dig,2014,34(2):100-104.(in Chinese)张莉,王龙,杨根妹.肝硬化门静脉血栓形成的相关危险因素分析[J].中华消化杂志,2014,34(2):100-104.

[14]LEEBEEK FW,KLUFT C,KNOT EA,et al.A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis[J].Gastroenterology,1991,101(5):1382-1390.

[15]AMITRAN L,GUARDASCIONE MA,BRACACCIO V,et al.Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis[J].J Hepatol,2004,40(5):736-741.

[16]TUDWAY D,SANGSTER C.Utrasound diagnosis of portal vein thrombosis:following splenentomy[J].Postgrad Med J,1986,62(734):1153.

[17]MENG L,LIU YX,YAO WT.Relation between neutrophil with leuocyte and gastroesophageal varices bleeding in patients with hepatocirrhosis[J].Shandong Med J,2012,52(28):26-27.(in Chinese)孟磊,刘云霞,姚文暾.肝硬化患者中性粒细胞及白细胞与胃食管静脉曲张破裂出血的关系[J].山东医药,2012,52(28):26-27.

施引文献

资源附件(0)

访问统计